Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Transition to chronic pain: opportunities for novel therapeutics


Although chronic pain is one of the most important medical problems facing society, there has been very limited progress in the development of novel therapies for this condition. Here, we discuss high-impact research priorities to reduce the number of people transitioning from acute to chronic intractable pain.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others


  1. Ji, R. R., Chamessian, A. & Zhang, Y. Q. Science 354, 572–577 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Apkarian, A. V., Baliki, M. N. & Farmer, M. A. Curr. Opin. Neurol. 26, 360–367 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Denk, F., McMahon, S. B. & Tracey, I. Nat. Neurosci. 17, 192–200 (2014).

    Article  PubMed  CAS  Google Scholar 

  4. Skolnick, P. & Volkow, N. D. Neuron 92, 294–297 (2016).

    Article  PubMed  CAS  Google Scholar 

  5. Braz, J. M. et al. Neuron 74, 663–675 (2012).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Gewandter, J. S. et al. Pain 156, 1184–1197 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

Download references


We thank the Interagency Pain Research Coordinating Committee of the US National Institutes of Health, who facilitated and provided financial support for meetings of the working group.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Theodore J. Price.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information


Federal Pain Research Strategy:

NIH policy:

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Price, T.J., Basbaum, A.I., Bresnahan, J. et al. Transition to chronic pain: opportunities for novel therapeutics. Nat Rev Neurosci 19, 383–384 (2018).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing